Your Trial Is In Jeopardy. Time Is Critical.
Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.
FDA-mandated ocular assessments are derailing timelines, including phase 2/3 MDD, Bipolar, and Epilepsy trials. We fix the ocular endpoint risk—fast.
Get a Trial Rescue Plan
We are the industry experts in deploying certified, point-of-need ophthalmic teams to rescue studies.
- 40+ Clinical Trials Stabilized
- 48 States Nationwide Coverage
- 85,000+ Eye Assessments Administered
Time is critical. Schedule time now to protect your endpoints and regain timeline control.
"While working with 20/20 Onsite for previous and current studies, we have been able to provide ophthalmological services that were previously not feasible for our clinical units. Doing so has been very successful in providing safety and ophthalmological oversight of study participants – as required by good clinical practices and the sponsor protocol."
- Dr. David Wyatt, Vice-President and Global Medical Lead, Syneos Health
Trusted by leading sponsors, CROs, and sites
- Point of Need: 100% Screening timelines met across all business operations.
- Data Integrity: 98% Data accuracy submission rate.
- Patient Retention: 91% Patient retention rate vs industry standard 70%.
- Patient Centricity: 95+ Patient NPS score.